Author

Kylie Calderon

University of Arizona

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1

Frequent Co-Authors

Danielle A. BeckteliD· 2 shared Frankie G. GarciaiD· 2 shared Jacob C. ZbeskoiD· 2 shared Kristian P. DoyleiD· 2 shared Marco A. Tavera-Garcia· 2 shared Rick G. SchnellmanniD· 2 shared Thuy‐Vi V. NguyeniD· 2 shared Amanda G. Chung· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Danielle A. BecktelORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Post-stroke administration of the p75 neurotrophin receptor modulator, LM11A-31, attenuates chronic changes in brain metabolism, increases neurotransmitter levels, and improves recovery

Thuy‐Vi V. Nguyen, Rachel H. Crumpacker, Kylie Calderon, Frankie G. Garcia, Jacob C. Zbesko, Jennifer Beischel Frye, Selena Gonzalez, Danielle A. Becktel, Tao Yang, Marco A. Tavera-Garcia, Helena Willington Morrison, Rick G. Schnellmann, Frank M. Longo, Kristian P. Doyle

This study shows that LM11A-31, a p75NTR modulator, improves stroke recovery by enhancing brain metabolism, neurotransmitter levels, and reducing neurodegeneration in mice.

Journal of Pharmacology and Experimental Therapeutics · Dec 10, 2021Peer-reviewedNeuroscience

Repeated administration of 2-hydroxypropyl-β-cyclodextrin (HPβCD) attenuates the chronic inflammatory response to experimental stroke

Danielle A. Becktel, Jacob C. Zbesko, Jennifer B. Frye, Amanda G. Chung, Megan Hayes, Kylie Calderon, Jeffrey W. Grover, Anna Li, Frankie G. Garcia, Marco A. Tavera-Garcia, Rick G. Schnellmann, Hsin-Jung Joyce Wu, Thuy‐Vi V. Nguyen, Kristian P. Doyle

This study shows that repeated HPβCD treatment reduces chronic inflammation and cognitive decline after stroke by modulating lipid metabolism and immune responses.

Journal of Neuroscience · Nov 24, 2021Peer-reviewedNeuroscience